Prevalence of HIV Type 1 Antiretroviral Drug Resistance Mutations in Vietnam: A Multicenter Study

被引：22
|
作者：
Dean, Jonathan [2 ,3 ,4 ]
Thu Hong Ta Thi [1 ,2 ,3 ]
Dunford, Linda [2 ,3 ,4 ]
Carr, Michael J. [2 ,3 ,4 ]
Linh Thuy Nguyen [1 ,2 ,3 ]
Coughlan, Suzie [2 ,3 ,4 ]
Connell, Jeff [2 ,3 ,4 ]
Hien Tran Nguyen [1 ,2 ,3 ]
Hall, William W. [2 ,3 ,4 ]
Lan Anh Nguyen Thi [1 ,2 ,3 ]
机构：
[1] Natl Inst Hyg & Epidemiol, Lab Mol Diagnost, Hanoi, Vietnam
[2] Ireland Vietnam Blood Borne Virus Initiat IVVI, Dublin, Ireland
[3] Ireland Vietnam Blood Borne Virus Initiat IVVI, Hanoi, Vietnam
[4] Univ Coll Dublin, Natl Virus Reference Lab, Dublin 2, Ireland
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2011年 / 27卷 / 07期
关键词：
INTERNAL CONTROL; PCR ASSAY; PROVINCE; CHINA;
D O I：
10.1089/aid.2011.0013
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The prevalence of HIV-1 drug resistance mutations (DRMs) was determined for a cross-section of individuals (n = 8654) in five centers across Vietnam (Hanoi, Hai Phong, Da Nang, Khanh Hoa, and Can Tho) between 2008 and 2009. Following serological screening for HIV infection, HIV-1 viral load was determined, using an in-house real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay. Samples with quantifiable viral loads [all either commercial sex workers (CSW) or intravenous drug users (IDU)] underwent DRM analysis. Sequences were obtained for 92 treatment-naive individuals, the majority of whom were infected with HIV-1 CRF01_AE (99%), with one instance of subtype A1 also detected. DRMs were detected in seven treatment-naive individuals (7.6%). The most common DRMs observed were M184V, V75A/M, M41L, and K65R (NRTI) and K103N, G190A, and Y181C (NNRTI). Overall, the data from this first multicenter survey of DRMs in Vietnam indicate that the problem of transmitted drug resistance is of major concern in the highest-risk groups of IDU and CSW.
引用
收藏
页码：797 / 801
页数：5
相关论文
共 50 条
  • [41] Prevalence of multiple-class antiretroviral drug resistance in HIV-1-treated patients
    Masquelier, B
    Costagliola, D
    Schmuck, A
    Cottalorda, J
    Schneider, V
    Izopet, J
    Descamps, D
    Poggi, C
    Brun-Vézinet, F
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : U70 - U70
  • [42] Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy
    Bannister, Wendy P.
    Cozzi-Lepri, Alessandro
    Kjaer, Jesper
    Clotet, Bonaventura
    Lazzarin, Adriano
    Viard, Jean-Paul
    Kronborg, Gitte
    Duiculescu, Dan
    Beniowski, Marek
    Machala, Ladislav
    Phillips, Andrew
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) : 901 - 911
  • [43] Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort
    Payne, Brendan A. I.
    Nsutebu, Emmanuel F.
    Hunter, Ewan R.
    Olarinde, Olufunso
    Collini, Paul
    Dunbar, James A. T.
    Basta, Medhat S. T.
    Elston, James W. T.
    Schmid, Matthias L.
    Thaker, Hiten
    Chadwick, David R.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (03) : 464 - 468
  • [44] Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
    Hannah Castro
    Deenan Pillay
    Caroline Sabin
    David T Dunn
    [J]. BMC Medical Research Methodology, 12
  • [45] Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection
    Biagetti, Carlo
    Bon, Isabella
    Vitone, Francesca
    Schiavone, Pasqua
    Borderi, Marco
    Pavoni, Michele
    Verucchi, Gabriella
    Re, Maria Carla
    Chiodo, Francesco
    [J]. NEW MICROBIOLOGICA, 2009, 32 (02): : 129 - 134
  • [46] Prevalence of resistance mutations in HIV-1-Infected Hondurans at the beginning of the national Antiretroviral therapy program
    Lloyd, Bradley
    O'Connell, Robert J.
    Michael, Nelson L.
    Aviles, Ricardo
    Palou, Elsa
    Hernandez, Rosalinda
    Cooley, John
    Jagodzinski, Linda L.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (04) : 529 - 535
  • [47] Stable and Low Prevalence of Transmitted HIV Type 1 Drug Resistance Despite Two Decades of Antiretroviral Therapy in Hong Kong
    Wong, K. H.
    Chan, W. K.
    Yam, W. C.
    Chen, J. H. K.
    Alvarez-Bognar, F. R.
    Chan, K. C. W.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : 1079 - 1085
  • [48] Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative study
    Holodniy, M
    Charlebois, ED
    Bangsberg, DR
    Zolopa, AR
    Schulte, M
    Moss, AR
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (08) : 543 - 551
  • [49] Low Prevalence of HIV Type 1 Drug Resistance Mutations in Untreated, Recently Infected Patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: The ANRS 12134 Study
    Ayouba, Ahidjo
    Lien, Truong T. X.
    Nouhin, Janin
    Vergne, Laurence
    Aghokeng, Avelin Fobang
    Ngo-Giang-Huong, Nicole
    Diop, Halimatou
    Kane, Coumba Toure
    Valea, Diane
    Rouet, Francois
    Joulia-Ekaza, Dominique
    Toni, Thomas D'Aquin
    Nerrienet, Eric
    Ngole, Eitel Mpoudi
    Delaporte, Eric
    Costagliola, Dominique
    Peeters, Martine
    Chaix, Marie-Laure
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (11) : 1193 - 1196
  • [50] Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil
    Bahls, Larissa Danielle
    Canezin, Pedro Henrique
    Vissoci Reiche, Edna Maria
    Couto Fernandez, Jose Carlos
    Colleti Dias, Jose Ricardo
    Fernandes Meneguetti, Vera Alice
    Ueda, Luis Toshio
    Bertolini, Dennis Armando
    [J]. AIDS RESEARCH AND THERAPY, 2019, 16 (1)
12345